BriaCell Therapeutics Corp (BCTX)
0.5934
-0.01
(-1.03%)
USD |
NASDAQ |
Nov 14, 16:00
0.6002
+0.01
(+1.15%)
After-Hours: 18:17
BriaCell Therapeutics EPS Diluted (Quarterly): -0.07 for July 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
July 31, 2024 | -0.07 |
April 30, 2024 | 0.11 |
January 31, 2024 | -0.71 |
October 31, 2023 | -0.50 |
July 31, 2023 | -0.15 |
April 30, 2023 | -0.32 |
January 31, 2023 | -0.77 |
October 31, 2022 | -0.07 |
July 31, 2022 | -0.03 |
April 30, 2022 | -0.65 |
January 31, 2022 | 0.71 |
October 31, 2021 | -1.81 |
July 31, 2021 | -1.055 |
April 30, 2021 | 0.63 |
January 31, 2021 | -0.30 |
October 31, 2020 | -0.54 |
July 31, 2020 | -1.334 |
April 30, 2020 | -0.6994 |
January 31, 2020 | -1.975 |
October 31, 2019 | -1.830 |
July 31, 2019 | -2.641 |
April 30, 2019 | -1.929 |
January 31, 2019 | -2.216 |
October 31, 2018 | -1.472 |
July 31, 2018 | 6.977 |
Date | Value |
---|---|
April 30, 2018 | -2.336 |
January 31, 2018 | -2.432 |
October 31, 2017 | -2.339 |
July 31, 2017 | -9.420 |
April 30, 2017 | -4.397 |
January 31, 2017 | -2.290 |
October 31, 2016 | -2.236 |
July 31, 2016 | -2.018 |
April 30, 2016 | -2.39 |
January 31, 2016 | -2.146 |
October 31, 2015 | -2.295 |
July 31, 2015 | -1.550 |
April 30, 2015 | -2.495 |
January 31, 2015 | -9.427 |
October 31, 2014 | -0.3086 |
July 31, 2014 | -125.17 |
April 30, 2014 | -8.900 |
January 31, 2014 | -1.348 |
October 31, 2013 | -2.573 |
July 31, 2013 | 0.1726 |
April 30, 2013 | -1.878 |
January 31, 2013 | -1.443 |
October 31, 2012 | -1.334 |
July 31, 2012 | -9.530 |
April 30, 2012 | -9.937 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.975
Minimum
Jan 2020
0.71
Maximum
Jan 2022
-0.5017
Average
-0.50
Median
Oct 2023
EPS Diluted (Quarterly) Benchmarks
CeCors Inc | -- |
Venus Concept Inc | -3.05 |
Aurinia Pharmaceuticals Inc | 0.10 |
Edesa Biotech Inc | -0.52 |
Lexaria Bioscience Corp | -0.13 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -1.214M |
Total Expenses (Quarterly) | 5.768M |
Enterprise Value | 20.53M |
Earnings Yield | -197.2% |